Search

Search Constraints

You searched for: Author/Creator He, Li-Zhen

Search Results

1. CD27 stimulation unveils the efficacy of linked class I/II peptide vaccines in poorly immunogenic tumors by orchestrating a coordinated CD4/CD8 T cell response. (2nd December 2018)

2. 550 An Axl-targeting monoclonal antibody that inhibits Axl activity and potently stimulates the innate immune response. (9th November 2020)

3. 406 CDX527–01, a phase 1 dose-escalation and expansion study of the PD-L1xCD27 bispecific antibody CDX-527 in patients with advanced malignancies. (9th November 2020)

4. 550 An Axl-targeting monoclonal antibody that inhibits Axl activity and potently stimulates the innate immune response. (9th November 2020)

5. 406 CDX527–01, a phase 1 dose-escalation and expansion study of the PD-L1xCD27 bispecific antibody CDX-527 in patients with advanced malignancies. (9th November 2020)

6. The mechanism of anti-tumor immunity induced by varlilumab, a CD27 agonist mAb, is model dependent. (4th November 2015)

7. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one: National Harbor, MD, USA. 9-13 November 2016. (16th November 2016)

9. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one. Issue 1 (November 2016)

10. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one. Issue 1 (November 2016)